News
17 news
-
5 questions with Dr François-Xavier Danlos about therapeutic cancer vaccines
InterpretationTherapeutic cancer vaccines are making significant progress in clinical development. The ESMO Congress, which begins on 23 October, will provide an opportunity to learn about new data on...
-
Drug shortages: Gustave Roussy becomes the only Cancer Centre in France authorised to produce Special Hospital Preparations
InstitutionalThe Clinical Pharmacy Department at Gustave Roussy has been authorised by the French Ministry of Health to manufacture Special Hospital Preparations (SHPs). Granted for a period of seven...
-
Personalising Breast Cancer Treatments: 5 Questions with Dr Barbara Pistilli
Clinical & Scientific AdvancesAdvances in treatment and patient care mean that five-year net survival for breast cancer now reaches 88%1 in France. However, with around 60,000 new cases diagnosed each year in France...
-
Treating Children Differently: The Birth of Paediatric Oncology at Gustave Roussy
Interpretation« Great advances in oncology » - Episode 4/4. In 1952, Dr Odile Schweisguth established Europe’s first paediatric oncology department at Gustave Roussy, at a time when the specialty was...
-
Research focus – Antibody Drug Conjugates, Nuclear Medicine… Four other Breakthroughs to Watch
InterpretationLast quarter also brought several other noteworthy developments. Researchers reported that delivering part of chemotherapy more precisely after surgery can help treat liver metastases...
-
Seeing Cancer in Its DNA: The Origins of Precision Medicine
Interpretation« Great advances in oncology » – Episode 3/4. Now considered indispensable in oncology, molecular profiling of tumours is one of the cornerstones of precision medicine. As early as 2011...
-
From Gene Discovery to Treatment: How LAG‑3 Opened a New Path in Immunotherapy
Interpretation“Great Advances in Oncology” – Episode 2/4. Discovered more than three decades ago at Gustave Roussy, the LAG‑3 gene is now at the heart of the development of new anticancer treatments...
-
The TNM Classification: An Invention Born at Gustave Roussy, Now the Universal Language of Cancer
Interpretation"Great Advances in Oncology” – Episode 1/4. Developed in the 1940s by Professor Pierre Denoix, the TNM classification has gradually become the tool that enables oncologists worldwide to...
8 results per page